‹ ›
MYP_160124
← PREVIOUS NEXT → BACK
Basic Information
Unnamed
Antimicrobial
Antiviral
Antiviral ▸ Antiviral mechanism ▸ Viral assembly inhibition ▸ Assembly inhibitor
Standard
8 amino acids
C36H68N12O10S
Standard
Sequence
SLLGRMKG
Physicochemical Analysis
861.06 Da
11.00
1.46
1.25
0.1824
-0.06
0.29
-0.06
-1.86
97.50
0.0000
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
375.17
-3.72
14.0
13.0
31.0
59.0
0.0
7.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0124840 VERIFIED: YES
Provenance & Taxonomy
not reported [other]
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Antiviral
PaperAVPdb: a database of experimentally validated antiviral peptides targeting medically important viruses PMID24285301 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/24285301/
RECORD: Rec_0209285 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Synthetic peptide
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral Assembly inhibitor
Hepatitis B virus (Viral assembly); HepG2
6.4 μM
Dye reduction assay
PaperPeptides that block hepatitis B virus assembly: analysis by cryomicroscopy, mutagenesis and transfection. | Bottcher B, Tsuji N, Takahashi H, Dyson MR, Zhao S, Crowther RA, Murray K. | EMBO J. 1998 | PMID:9843489 PMID9843489 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/9843489/
RECORD: Rec_0222020 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Synthetic peptide
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral Assembly inhibitor
Hepatitis B virus (Viral assembly); HepG2
6.4 μM
Phage binding assay
PaperHepatitis B virus inhibitors | Kenneth Murray, Michael Richard Dyson | Biogen, Inc., Cambridge MA | Patent:US6544520 Evidence URLhttps://patents.google.com/patent/US6544520/en PatentUS6544520
RECORD: Rec_0241342 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Synthetic peptide
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral Assembly inhibitor
Hepatitis B virus (Viral assembly); HepG2
26.2 μM
Phage binding assay
PaperHepatitis B virus inhibitors | Kenneth Murray, Michael Richard Dyson | Biogen, Inc., Cambridge MA | Patent:US6544520 Evidence URLhttps://patents.google.com/patent/US6544520/en PatentUS6544520